TEVA-DASATINIB
Analogs of TEVA-DASATINIB
Find cheaper analogs and generic equivalents for TEVA-DASATINIB.
Active Ingredient: DASATINIB (DASATINIB MONOHYDRATE)
Product Overview
About TEVA-DASATINIB
TEVA-DASATINIB is a prescription medication containing the active ingredient DASATINIB (DASATINIB MONOHYDRATE), used in the treatment of certain types of cancer, including Philadelphia chromosome-positive (Ph+) chronic myeloid leukemia (CML) and Philadelphia chromosome-positive (Ph+) acute lymphoblastic leukemia (ALL).
Key Benefits & Uses
- Treatment of Philadelphia chromosome-positive (Ph+) chronic myeloid leukemia (CML)
- Treatment of Philadelphia chromosome-positive (Ph+) acute lymphoblastic leukemia (ALL)
- Management of resistant or intolerant disease in patients with Ph+ CML
Active Ingredient & Action
DASATINIB (DASATINIB MONOHYDRATE) is a tyrosine kinase inhibitor that works by blocking the activity of certain enzymes (tyrosine kinases) involved in the growth and spread of cancer cells. By inhibiting these enzymes, DASATINIB helps to slow or stop the growth of cancer cells, thereby reducing the size of tumors and alleviating symptoms.
Important Notes
TEVA-DASATINIB is available only by prescription and should be used under the guidance of a qualified healthcare professional. It is essential to follow the recommended dosage and administration instructions carefully to minimize the risk of adverse effects. Patients taking TEVA-DASATINIB should be monitored regularly for signs of potential side effects, such as bleeding, liver damage, and pancreatitis.
Visitor ratings
Help others by rating how useful this product page is.
No ratings yet — be the first.